ChemDAQ has been working to eliminate workplace exposure to toxic chemicals for decades. Our focus has always been on hard-to-detect sterilant and disinfectant gases and chemical vapors, and we are continuously developing new technologies that bring you better performance.

Our patented ethylene oxide sensor technology was initially deployed to protect hospitals and medical device sterilization workers across the United States. We have since broadened our portfolio to include hydrogen peroxide and peracetic acid sensors and monitors, and we now serve more than 600 customers worldwide including leading companies in healthcare, food and beverage packaging, protein processing, medical device manufacturing, and supply chain.

Our mission revolves around 3 primary principles – creating safer workplaces, reducing risk and providing next-level protection in work environments that rely on gases used for sterilization, disinfection, and antimicrobial applications.

ChemDAQ is a leading advocate of workplace safety practices, partnering with government agencies, standards and trade organizations, and of course our valued customers to drive best practices, standards, and education around the safe use of these highly toxic but essential chemicals.

ChemDAQ customers span six continents and range from large multinational corporations to single facility businesses. Hundreds of major healthcare systems, Veterans Health Administration facilities, and leading food and beverage companies rely on ChemDAQ’s monitoring technology every day.

Our Leadership

David Hilliker, Founder & CEO

David Hilliker is the Founder and CEO of ChemDAQ Inc., where he has worked for more than 25 years to build the business. Known as a trailblazer in the gas detection industry, David has dedicated his life to workplace and employee safety, educating workers and employers alike about the dangers of sterilant and antimicrobial gases. Prior to founding ChemDAQ, David served as the President and CEO of several companies, including MedEquip Services, Inc. and Praesidium Technologies, Inc. As President & CEO, he continues to lead ChemDAQ in its mission to eliminate workplace exposure to toxic chemicals through innovative monitoring and control solutions, industry-leading partnerships and superior safety expertise.

Alex Hilliker, Executive Vice President

Alex Hilliker is ChemDAQ’s Executive Vice President, leading efforts to establish new sales channels, expand partnerships, and increase global brand recognition in the markets ChemDAQ serves. Known for his ability to build dynamic business relationships across organizations, Alex focuses on elevating ChemDAQ’s mission and values in the United States and across the world. Previously, Alex served as a Manager in Deloitte Consulting's Government and Public Services practice, supporting clients at the Departments of Veterans Affairs, Defense, and Homeland Security. Alex earned a Masters Degree in Public Administration from The George Washington University and a BA in Political Science from the University of Michigan.

Dr. Richard Warburton, CTO & General Counsel

Dr. Richard Warburton has been with ChemDAQ for more than two decades and currently serves as Chief Technology Officer (CTO) and General Counsel. He is responsible for new product development, managing the R&D and Engineering teams, developing legal policies, and protecting the company’s intellectual property. Richard obtained his BS in Chemistry with Physics and Ph.D. in Chemistry from the University of Southampton, and his JD from Duquesne University. Richard spent four years as a post-doc. at the University of Kansas before moving to Pittsburgh where he worked for Draeger Safety and Industrial Scientific before joining ChemDAQ. He has over 20 publications and 30 patents and pending patent applications; and he is also the author or co-author of three books.

Interested in working for ChemDAQ? Check out our LinkedIn Page for more information on positions for which we are currently hiring: https://www.linkedin.com/company/chemdaq